325 related articles for article (PubMed ID: 16055434)
1. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
[TBL] [Abstract][Full Text] [Related]
2. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States.
Becker L; Salameh W; Sferruzza A; Zhang K; ng Chen R; Malik R; Reitz R; Nasser I; Afdhal NH
Clin Gastroenterol Hepatol; 2009 Jun; 7(6):696-701. PubMed ID: 19514117
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
5. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
Toson EA; Shiha GE; Abdelgaleel AE
Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
[TBL] [Abstract][Full Text] [Related]
6. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
[TBL] [Abstract][Full Text] [Related]
7. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
8. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
[TBL] [Abstract][Full Text] [Related]
9. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
Myers RP; Benhamou Y; Imbert-Bismut F; Thibault V; Bochet M; Charlotte F; Ratziu V; Bricaire F; Katlama C; Poynard T
AIDS; 2003 Mar; 17(5):721-5. PubMed ID: 12646795
[TBL] [Abstract][Full Text] [Related]
10. The ability of Hepascore to predict liver fibrosis in chronic liver disease: a meta-analysis.
Huang Y; Adams LA; Joseph J; Bulsara MK; Jeffrey GP
Liver Int; 2017 Jan; 37(1):121-131. PubMed ID: 26991726
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
[TBL] [Abstract][Full Text] [Related]
12. FibroScore for the non-invasive assessment of liver fibrosis in chronic viral hepatitis.
Ashraf S; Ahmed SA; Ahmed J; Ali N
J Coll Physicians Surg Pak; 2012 Feb; 22(2):84-90. PubMed ID: 22313643
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
[TBL] [Abstract][Full Text] [Related]
14. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
15. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
17. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.
Alboraie M; Khairy M; Elsharkawy A; Elsharkawy M; Asem N; Abo El-Seoud AR; Elghamry FG; Esmat G
Saudi J Gastroenterol; 2014; 20(3):170-4. PubMed ID: 24976280
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.
El-Kamary SS; Mohamed MM; El-Raziky M; Shardell MD; Shaker OG; ElAkel WA; Esmat G
Liver Int; 2013 Aug; 33(7):982-90. PubMed ID: 23509874
[TBL] [Abstract][Full Text] [Related]
19. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients.
Attallah AM; El-Far M; Abdel Malak CA; Omran MM; Farid K; Hussien MA; Albannan MS; Attallah AA; Elbendary MS; Elbesh DA; Elmenier NA; Abdallah MO
Ann Hepatol; 2015; 14(2):225-33. PubMed ID: 25671832
[TBL] [Abstract][Full Text] [Related]
20. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
